Integrated bioinformatics analysis identifies established and novel TGFβ1-regulated genes modulated by anti-fibrotic drugs
暂无分享,去创建一个
V. Thannickal | E. Neptune | J. Mobley | M. McDonald | D. Chanda | J. Chiles | A. Wilson | P. L. Kumar | Shah Ashish | Merry-Lynn N. McDonald
[1] M. Zhang,et al. The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1 , 2021, Science advances.
[2] Y. Gan,et al. Pharmaceutical targeting of succinate dehydrogenase in fibroblasts controls bleomycin-induced lung fibrosis , 2021, Redox biology.
[3] Mark G. Jones,et al. Idiopathic pulmonary fibrosis: Disease mechanisms and drug development. , 2020, Pharmacology & therapeutics.
[4] G. Washko,et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. , 2020, Science advances.
[5] S. Hirakawa,et al. Potential role of transforming growth factor‐beta 1/Smad signaling in secondary lymphedema after cancer surgery , 2020, Cancer science.
[6] T. Luckhardt,et al. Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis , 2020, Drug, healthcare and patient safety.
[7] J. Cortijo,et al. Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation , 2020, Oncotarget.
[8] Sun Wook Cho,et al. Multifaceted Actions of Succinate as a Signaling Transmitter Vary with Its Cellular Locations , 2020, Endocrinology and metabolism.
[9] S. Majewski,et al. Epithelial Alarmins in Serum and Exhaled Breath in Patients with Idiopathic Pulmonary Fibrosis: A Prospective One-Year Follow-Up Cohort Study , 2019, Journal of clinical medicine.
[10] M. Peters-Golden,et al. Molecular determinants of mesenchymal cell activation in fibroproliferative diseases , 2019, Cellular and Molecular Life Sciences.
[11] Y. Kondoh,et al. Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF). , 2019, Journal of thoracic disease.
[12] K. Ikeo,et al. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1 , 2019, Respiratory Research.
[13] K. Schenke-Layland,et al. Cardiac fibrosis - A short review of causes and therapeutic strategies. , 2019, Advanced drug delivery reviews.
[14] V. Thannickal,et al. The Aging Lung and Idiopathic Pulmonary Fibrosis. , 2019, The American journal of the medical sciences.
[15] Rainer Schneider,et al. A Unique Family of Neuronal Signaling Proteins Implicated in Oncogenesis and Tumor Suppression , 2019, Front. Oncol..
[16] Si-jia Chen,et al. Micheliolide ameliorates renal fibrosis by suppressing the Mtdh/BMP/MAPK pathway , 2019, Laboratory Investigation.
[17] T. Suda,et al. The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype , 2018, European Respiratory Review.
[18] M. Cho,et al. Suppression of Cavernosal Fibrosis in a Rat Model. , 2018, Sexual medicine reviews.
[19] W. Seeger,et al. Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis , 2018, European Respiratory Journal.
[20] Eun-Hee Cho. Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis , 2018, Front. Endocrinol..
[21] D. Sheppard,et al. TGF-β1 Signaling and Tissue Fibrosis. , 2018, Cold Spring Harbor perspectives in biology.
[22] R. Lockey,et al. The dawn of succinylation: a posttranslational modification. , 2018, American journal of physiology. Cell physiology.
[23] L. Richeldi,et al. Nintedanib for the treatment of idiopathic pulmonary fibrosis , 2018, Expert opinion on pharmacotherapy.
[24] Jacob K. Asiedu,et al. The Drug Repurposing Hub: a next-generation drug library and information resource , 2017, Nature Medicine.
[25] N. Sandbo,et al. Tensin 1 Is Essential for Myofibroblast Differentiation and Extracellular Matrix Formation , 2017, American journal of respiratory cell and molecular biology.
[26] P. Shi,et al. miR-21 enhances cardiac fibrotic remodeling and fibroblast proliferation via CADM1/STAT3 pathway , 2017, BMC Cardiovascular Disorders.
[27] W. Grizzle,et al. Surveying the serologic proteome in a tissue‐specific kras(G12D) knockin mouse model of pancreatic cancer , 2016, Proteomics.
[28] S. Plymate,et al. Classical and Non-Classical Roles for Pre-Receptor Control of DHT Metabolism in Prostate Cancer Progression , 2016, Hormones and Cancer.
[29] V. Thannickal,et al. Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now? , 2016, Drugs.
[30] C. Lim,et al. Mesothelial cells in tissue repair and fibrosis , 2015, Front. Pharmacol..
[31] D. Kang,et al. Effect of aldosterone on epithelial-to-mesenchymal transition of human peritoneal mesothelial cells , 2015, Kidney research and clinical practice.
[32] A. Ganser,et al. Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction , 2015, Nature Medicine.
[33] David S. Wishart,et al. T3DB: the toxic exposome database , 2014, Nucleic Acids Res..
[34] A. Gaggar,et al. Fibrosis: ultimate and proximate causes. , 2014, The Journal of clinical investigation.
[35] L. Leinwand,et al. Roles of transforming growth factor‐β1 and OB‐cadherin in porcine cardiac valve myofibroblast differentiation , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] N. Laird,et al. A comparative analysis of family-based and population-based association tests using whole genome sequence data , 2014, BMC Proceedings.
[37] H. Collard,et al. Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. , 2014, American journal of respiratory and critical care medicine.
[38] P. Bradding,et al. CADM1 Is a Key Receptor Mediating Human Mast Cell Adhesion to Human Lung Fibroblasts and Airway Smooth Muscle Cells , 2013, PloS one.
[39] L. Feuk,et al. Diagnostic interpretation of array data using public databases and internet sources , 2012, Human mutation.
[40] Minghua Wu,et al. Cadherin‐11 contributes to pulmonary fibrosis: potential role in TGF‐β production and epithelial to mesenchymal transition , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] Stef van Buuren,et al. MICE: Multivariate Imputation by Chained Equations in R , 2011 .
[42] Daniel R. Salomon,et al. Strategies for aggregating gene expression data: The collapseRows R function , 2011, BMC Bioinformatics.
[43] F. Martinez,et al. NADPH Oxidase-4 Mediates Myofibroblast Activation and Fibrogenic Responses to Lung Injury , 2009, Nature Medicine.
[44] S. Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[45] T. Wynn,et al. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. , 2007, The Journal of clinical investigation.
[46] J. Adamski,et al. Multifunctionality of human 17β-hydroxysteroid dehydrogenases , 2006, Molecular and Cellular Endocrinology.
[47] F. Martinez,et al. Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury. , 2005, The American journal of pathology.
[48] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[49] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. , 2015, The New England journal of medicine.
[50] Arthur Liberzon,et al. A description of the Molecular Signatures Database (MSigDB) Web site. , 2014, Methods in molecular biology.
[51] S. Rosselot. Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[52] J. Adamski,et al. Multifunctionality of human 17beta-hydroxysteroid dehydrogenases. , 2006, Molecular and cellular endocrinology.